Rapid responses are electronic comments to the editor. They enable our users to debate issues raised in articles published on bmj.com. A rapid response is first posted online. If you need the URL (web address) of an individual response, simply click on the response headline and copy the URL from the browser window. A proportion of responses will, after editing, be published online and in the print journal as letters, which are indexed in PubMed. Rapid responses are not indexed in PubMed and they are not journal articles. The BMJ reserves the right to remove responses which are being wilfully misrepresented as published articles.
This article is jumping the gun a little here. The legislation around e cigarette use in the UK is currently under review and no such move has been confirmed. As it stands current legislation of e cigarettes and other nicotine containing products will continue under consumer control law until at a cut off date in 2016 when the new EU legislation regarding nicotine containing products will come into effect. This new EU legislation regarding nicotine containing products allows liquids containing up to 20mg nicotine per ml to be sold as they currently are under normal consumer law and products containing higher concentrations of nicotine to be medically licensed should the pharmaceutical industry wish to do so (and you can bet your bottom dollar that they will).